Ad
Wednesday, 30 November 2016
GSK biotech asthma drug wins UK approval after extra price cut
LONDON (Reuters) - GlaxoSmithKline's new injectable asthma drug Nucala has been recommended for use in Britain's state-run health service in the most severe patients, after the drugmaker provided further analyses on its use and made an additional price cut.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment